Cardiac toxicity associated with capecitabine therapy.
Saif
M Wasif
MW
Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NCI-Navy Medical Oncology, National Naval Medical Center, Bethesda 20889-5105, USA.
Quinn
Mary G
MG
Thomas
Rebecca R
RR
Ernst
Aaron
A
Grem
Jean L
JL
D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000633:toxicity*; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005472:Fluorouracil / Q000031:analogs & derivatives; D006331:Heart Diseases / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011355:Prodrugs / Q000633:toxicity*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil